Adult stem cells |
• Option for patient-specific derivation |
• Limited proliferation capacity |
• Characterization of differentiation/maturation processes for potential in vitro or clinical use92,94,95,97–99
|
Liver progenitor cells |
• Committed to the hepatic lineage, facilitating differentiation |
• Scarce tissue availability • Low frequency in tissue |
Mesenchymal stem cells |
• Good availability (e.g. from bone marrow, placenta, umbilical cord) |
• Incomplete hepatic differentiation with current protocols |
Pluripotent stem cells |
• Unlimited growth |
• Fetal phenotype of differentiated cells with current protocols • Lack of standardized methods for cell differentiation and characterization |
• Use in drug metabolism and toxicity studies119,146,147 • Research on applications in regenerative medicine122
|
hESC |
• Differentiation not affected by epigenetic memory |
• Ethical considerations restrict research on hESC in dependence of national regulations |
hiPSC |
• Good availability • No ethical restrictions • Option for derivation from different individuals and patient groups |
• Epigenetic memory may impair hepatic differentiation |
• Analysis of genetic polymorphisms • Establishment of disease models149–153 • Drug testing with patient-specific cell lines for personalized medicine155
|